Enhabit’s Board Battle Continues, Advisory Firm Partially Sides With Activist Investor

One of home health care’s biggest public battles continued Thursday, as an outside advisory firm made its recommendations regarding the future of the Enhabit Inc. (NYSE: EHAB) board. AREX Capital Management – which owns 4.9% of Enhabit’s outstanding common shares – has been challenging Enhabit’s strategic direction for more than a year. Initially, the activist […]

Enhabit Defends Medicare Advantage Strategy, Overhead Costs

On Monday, Enhabit Inc. (NYSE: EHAB) defended its strategy of taking on more Medicare Advantage (MA) revenue over the last couple of years. It did so in yet another response to AREX Capital Management, an activist investor that owns 4.9% of Enhabit shares. Enhabit and AREX Capital – which wants to replace Enhabit’s current board […]

Enhabit Urges Shareholders To Trust Its Process, Vote Against Activist Investor’s Board Nominations

Enhabit Inc. (NYSE: EHAB) remains on the defensive against the activist investor AREX Capital Management. Last month, it provided more details around its completed strategic review, explaining the rationale behind remaining an independent company, in lieu of a merger or a sale. On Monday, it laid out its reasoning behind past struggles, its plan for […]

With Pressure From Activist Investor, Enhabit Reveals More Details Around Its Strategic Review

With pressure from an activist investor, Enhabit Inc. (NYSE: EHAB) has released more information surrounding its strategic review, which was completed earlier this month. Instead of a merger or sale, the Dallas-based home health and hospice company elected to remain an independent, public company. The activist investor, AREX Capital Management, previously said a sale was […]